scholarly journals Accuracy of the short‐form Montreal Cognitive Assessment: Systematic review and validation

2019 ◽  
Vol 34 (10) ◽  
pp. 1515-1525 ◽  
Author(s):  
Jennifer A. McDicken ◽  
Emma Elliott ◽  
Gareth Blayney ◽  
Stephen Makin ◽  
Myzoon Ali ◽  
...  
2015 ◽  
Author(s):  
Daniel K. Horton ◽  
Linda S. Hynan ◽  
Laura H. Lacritz ◽  
Heidi C. Rossetti ◽  
Myron F. Weiner ◽  
...  

2016 ◽  
Vol 87 (12) ◽  
pp. 1303-1310 ◽  
Author(s):  
David R Roalf ◽  
Tyler M Moore ◽  
David A Wolk ◽  
Steven E Arnold ◽  
Dawn Mechanic-Hamilton ◽  
...  

2021 ◽  
Vol 13 ◽  
Author(s):  
Ji-ping Tan ◽  
Xiaoxiao Wang ◽  
Shimin Zhang ◽  
Yiming Zhao ◽  
Xiaoyang Lan ◽  
...  

Background: There is a strong need for short and effective methods to screen for cognitive impairment. Recent studies have created short forms of the Montreal Cognitive Assessment (s-MoCA) in English-speaking populations. It is also important to develop a validated Chinese short version to detect cognitive impairment.Methods: Item response theory and computerized adaptive testing analytics were used to construct abbreviated MoCAs across a large neurological sample comprising 6,981 community-dwelling Chinese veterans.Results: Six MoCA items with high discrimination and appropriate difficulty were included in the s-MoCA. The Chinese short versions (sensitivity 0.89/0.90, specificity 0.72/0.77) are similar in performance to the full MoCA in identifying cognitive impairment (sensitivity 0.91, specificity 0.82).Conclusions: These short variants of the MoCA may serve as quick and effective instruments when the original MoCA cannot be feasibly administered in clinical services with a high patient burden and limited cognitive testing resources.


2019 ◽  
Vol 41 (1) ◽  
pp. 112-123 ◽  
Author(s):  
Thaís Malucelli Amatneeks ◽  
Amer Cavalheiro Hamdan

Abstract Introduction: There is evidence in the literature that cognitive impairment is more prevalent in individuals with chronic kidney disease (CKD) than in the general population. The Montreal Cognitive Assessment (MoCA) is an instrument with a good application profile for cognitive evaluation of patients with CKD-like impairments. The objective of this study is to perform a systematic review of MoCA use in the context of CKD. Method: The keywords "Montreal Cognitive Assessment", "Kidney Disease" and "Chronic Kidney Disease" were used to search the databases. The inclusion criteria were: a) empirical articles; b) approach to cognitive impairment in CKD; c) papers in Portuguese and English. Results: The studies were mostly cross-sectional, published in medical journals, with research carried out mostly in Europe. About 45% of the studies had samples of less than 150 participants and variations in the prevalence of cognitive impairment were found ranging from 28.9% to 74.6%. The cutoff point for the identification of the impairment presented variation between the studies. Discussion: The results' analysis demonstrates the need for more complete studies on MoCA scoring and adaptation in its different versions. We recommend to the health professionals who will use the results in the clinical setting that the interpretation of the results be made in the light of studies more related to the context lived by the patients. Conclusions: The instrument is efficient to be used in several stages and treatment modalities of the disease. We point to the need to adapt a cut-off point for the instrument in the different translations of the instrument.


Sign in / Sign up

Export Citation Format

Share Document